Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 37, 2002 - Issue 7
Submit an article Journal homepage
105
Views
203
CrossRef citations to date
0
Altmetric
Research Article

Inflammatory Bowel Disease A Positive Response to Infliximab in Crohn Disease: Association with a Higher Systemic Inflammation Before Treatment But Not With -308 TNF Gene Polymorphism

E. Louis
,
S. Vermeire
,
P. Rutgeerts
,
M. De Vos
,
A. Van Gossum
,
P. Pescatore
,
R. Fiasse
,
P. Pelckmans
,
H. Reynaert
,
G. D'Haens
,
M. Malaise
&
J. Belaiche
 show all
Pages 818-824 | Published online: 08 Jul 2009

  • Targan S, Hanauer S, van Deventer SJH, Mayer L, Present DH, Braakman T, et al. A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor-a for Crohn's disease. Crohn's disease cA2 Study Group. N Engl J Med 1997; 337:1029-35.
  • Present DH, Rutgeerts P, Targan S, Hanauer SB, Mayer L, van Hogezand RA, et al. Infliximab for the treatment of fistulas in patients with Crohn's disease. N Engl J Med 1999;340:1398-405.
  • van Dullemen HM, van Deventer SJ, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology 1995;109:129-35.
  • D'Haens G, van Deventer S, Van Hogezand R, et al. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: a European multicenter trial. Gastroenterology 1999;116:1029-34.
  • Baert FJ, D'Haens GR, Peelers M, Hiele MI, Schaible TB, Shealy D, et al. Tumor necrosis factor-a antibody (infliximab) therapy profoundly down-regulates the inflammation in Crohn's enterocolitis. Gastroenterology 1999;116:22-8.
  • van Deventer SJH. Review article: targeting TNFa as a key cytokine in the inflammatory processes of Crohn's disease--the mechanisms of action of infliximab. Aliment Pharmacol Ther 1999;13 Suppl 4:3-8.
  • Papadakis KA, Targan SR. Tumor necrosis factor: biology and therapeutic inhibitors. Gastroenterology 2000;119:1148-57.
  • Stevens C Waltz G, Singaram C, et al. Tumor necrosis factor a, interleukin-1 ß and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 1992;37:818-26.
  • Reinecker HC, Steffen M, Witthoeft T, et al. Enhanced secretion of tumor necrosis factor-alpha, IL-6, and IL-I beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 1993;94:174-81.
  • Schreiber S, Nikolau s S, Hampe J, et al. Tumor necrosi s factor-a and interleukin 1ß in relapse of Crohn's disease. Lancet 1999;353:459-61.
  • Louis E, Ribbens C, Godon A, Franchimont D, De Groote D, Hardy N, et al. Increased production of matrix metalloproteinase -3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease. Clin Exp Immunol 2000;120:241-6.
  • Fender SLF, Fell JME, Chamow SM, Askenazi A, McDonald TT. A p55 TNF receptor immunoadhesin prevents T cell-mediated intestinal injury by inhibiting matrix metalloproteinase production. J Immunol 1998;160:4098-103.
  • Rutgeerts P, D'Haens G, Targan S, et al. Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remisssion in Crohn's disease. Gastroenterology 1999;117:761-9.
  • Pagan EA, Dyck RF, Maton PN, Hodgson HJ, Chadwick VS, Petrie A, et al. Serum levels of C-reactive protein in Crohn's disease and ulcerative colitis. Eur J Clin Invest 1982; 12:351-9.
  • Saverymuttu SH, Hodgson HJ, Chadwick VS, Pepys, MB. Differing acute phase response in Crohn's disease and ulcerative colitis. Gut 1986;27:809-13.
  • Boirivant M, Leoni M, Tariciotti D, Fais S, Squencia O, Pallone F. The clinical significance of serum C reactive protein levels in Crohn's disease. Results of a prospective longitudinal study. J Clin Gastroenterol 1988;10:401-5.
  • Taylor KD, Plevy SE, Yang H, Landers CJ, Bary MJ, Rotter JI, et al. ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease. Gastroenterology 2001;120:1347-55.
  • Nedospaso v SA, Udalova IA, Kuprash DV, Tuetskaya RL. DNA sequence polymorphism at the human tumor necrosis factor (TNF) locus. Numerous TNF/lymphotoxin alleles tagged by two closely linked microsatellites in the upstream region of the lymphotoxin gene. J Immunol 1991;147:1053-9.
  • Wilson AG, de Vreis N, Pociot F, di Giovine FS, van der Putte LBA. Duff GW. An allelic polymorphism within the human tumor necrosis factor alpha promoter region is strongly associated with HLA Al, BS, and DR3 alleles. J Exp Med 1993;177:557-60.
  • Uglialoro AM, Turbay D, Pesavento PA, Delgado JC, Mckenzie FE, Gribbenj G, et al. Identification of three new single nucleotide polymorphisms in the human tumor necrosis factor alpha gene promoter. Tissue Antigen 1998;52:456-61.
  • Negoro K, Kinouchi Y, Hiwatashi N, Takahashi S, Takagi S, Satoh J, et al. Crohn's disease is associated with novel polymorphisms in the 5'-flanking region of the tumor necrosis factor gene. Gastroenterology 1999;117:1062-8.
  • Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor a promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-9.
  • Bouma G, Crusius JBA, Oudkerk Pool M, Kolkman JJ, von Blomberg BME, Kostense PJ, et al. Secretion of tumor necrosis factor a and lymphotoxin a in relation to polymorphism in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel disease. Scand J Immunol 1996;43:456-463.
  • Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafbntaine N, Roland S, et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-a production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998;113:401-6.
  • McGuire W, Hill AVS, Alsopp CEM, Greenwood BM, Kwiatkowski D. Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria. Nature 1994;371:508-11.
  • Roy S, McGuire W, Mascie-Taylor CGN, Saha B, Hazra SK, Hill AVS, et al. Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy. J Infect Dis 1997;176:530-2.
  • Conway DJ, Holland MJ, Bailey RL, Campbell AE, Mahdi OSM, Jennings R, et al. Scarring trachoma is associated with polymorphism in the tumor necrosis factor alpha (TNF-a) gene promoter and with elevated TNF-a levels in tear fluid. Infect Immun 1997;65:1003-6.
  • Cabrera M, Shaw MA, Sharpies C, Williams H, Castes M, Convit J, et al. Polymorphism in tumor necrosis factor gene associated with mucocutaneous leishmaniasis. J Exp Med 1995; 182:1259-64.
  • Mira JP, Cariou A, Grail F, Delclaux C, Losser MR, Heshmati F, et al. Association of TNF2, a TNF-a promoter polymorphism, with septic shock susceptibility and mortality. JAMA 1999;282:561-5.
  • Louis E, Peelers M, Franchimont D, Seidel L, Fontaine F, Demolin G, et al. Tumour necrosis factor (TNF) gene polymorphism in Crohn's disease (CD); influence on disease behaviour? Clin Exp Immunol 2000;119:64-8.
  • Best WR, Becktel JM, Singleton JW. Rederived values of the eight coefficients of the Crohn's disease activity index (CDAI). Gastroenterology 1979;77:843-6.
  • Bunce M, Taylor CJ, Welsh KI. Rapide HLA-DQB typing by eight PCR amplifications with sequence-specific primers (PCR-SSPX Human Immunol 1993;37:201-6.
  • Louis E, Satsangi J, Roussomoustakaki M, Parkes M, Fanning G, Welsh K, et al. Cytokine gene polymorphisms in inflammatory bowel disease. Gut 1996;39:705-10.
  • Louis E, Belaiche J, Van Kemseke C, Schaaf N, Mahieu P, Mary JY. Soluble interleukin-2 receptor in Crohn's disease. Assessment of disease activity and prediction of relapse. Dig Dis Sci 1995;40:1750-6.
  • Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998;115:182-205.
  • Louis E, Van Kemseke C, De Groote D, Franchimont P, Belaiche J. IL-6, TNF-a and soluble TNF-a receptor serum level in Crohn's disease. Gut 1994;35:A22.
  • Beutler B, Cerami A. Cachectin and tumor necrosis factor as two sides of the same biological coin. Nature 1986;320:584-6.
  • Brinkman BM, Zuijdeest D, Kaijzel EL, Breesveld FC, Verweij CL, et al. Relevance of the tumor necrosis factor alpha (TNF alpha)-308 promoter polymorphism in TNF alpha gene regulation. J Inflamm 1995;46:32-41.
  • Westendorp RGJ, Langermans JAM, Huizinga TWJ, Vermeij CL, Stuck A. Genetic influence on cytokine production and fatal meningococcal disease. Lancet 1997;349:170-3.
  • Mascheietti S, Hampe J, Kruis W, Raedler A, Reddig J, Schreiber S. Evaluation of TNF microsatellites and SNPs in a cohort of chronic active, therapy refractory Crohn's disease patients treated with anti-TNF alpha. Gastroenterology 2000; 188:A335.
  • Siegel SA, Shealy DJ, Nakada MT, et al. The mouse/human chimeric monoclonal antibody cA2 neutralizes TNF in vitro and protects transgenic mice from cachexia and TNF lethality in vivo. Cytokine 1995;7:15-25.
  • Knight DM, Trinh H, Le J, et al. Construction and initial characterizatio n of a mouse-human chimeric anti-TNF antibody. Mol Immunol 1993;30:1443-53.
  • Scallon BJ, Moore MA, Trinh DM, Ghrayeb J. Chimeric ant-TNF-a monoclonal antibody, cA2, binds recombinant transmembrane TNF-a and activates immune effector functions. Cytokine 1995;7:251-9.
  • Nikolaus S, Raedler A, Kühbacher T, Sfikas N, Fölsch UR, Schreiber S. Mechanisms in failure of infliximab for Crohn's disease. Lancet 2000;356:1475-9.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.